Stock Yards Bank & Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.53M | Sell |
10,027
-1,216
| -11% | -$186K | 0.05% | 179 |
|
|
2025
Q4 | $1.55M | Sell |
11,243
-125
| -1% | -$16.4K | 0.05% | 179 |
|
|
2025
Q3 | $1.46M | Sell |
11,368
-273
| -2% | -$33.3K | 0.05% | 185 |
|
|
2025
Q2 | $1.41M | Sell |
11,641
-65
| -0.6% | -$7.33K | 0.05% | 180 |
|
|
2025
Q1 | $1.3M | Sell |
11,706
-976
| -8% | -$104K | 0.05% | 184 |
|
|
2024
Q4 | $1.23M | Sell |
12,682
-6,605
| -34% | -$704K | 0.04% | 183 |
|
|
2024
Q3 | $2.22M | Sell |
19,287
-1,181
| -6% | -$134K | 0.07% | 151 |
|
|
2024
Q2 | $2.18M | Sell |
20,468
-98
| -0.5% | -$9.84K | 0.07% | 154 |
|
|
2024
Q1 | $1.99M | Buy |
20,566
+24
| +0.1% | +$2.46K | 0.07% | 165 |
|
|
2023
Q4 | $2.07M | Sell |
20,542
-1,764
| -8% | -$170K | 0.07% | 161 |
|
|
2023
Q3 | $2.27M | Sell |
22,306
-282
| -1% | -$28.6K | 0.09% | 148 |
|
|
2023
Q2 | $2.28M | Sell |
22,588
-748
| -3% | -$74.8K | 0.08% | 154 |
|
|
2023
Q1 | $2.15M | Buy |
23,336
+47
| +0.2% | +$4.11K | 0.08% | 154 |
|
|
2022
Q4 | $2.11M | Sell |
23,289
-685
| -3% | -$57.7K | 0.08% | 156 |
|
|
2022
Q3 | $1.82M | Buy |
23,974
+1,087
| +5% | +$90.1K | 0.08% | 160 |
|
|
2022
Q2 | $1.94M | Buy |
22,887
+20,196
| +751% | +$1.77M | 0.08% | 161 |
|
|
2022
Q1 | $236K | Hold |
2,691
| – | – | 0.01% | 249 |
|
|
2021
Q4 | $236K | Sell |
2,691
-37
| -1% | -$3.07K | 0.01% | 259 |
|
|
2021
Q3 | $223K | Sell |
2,728
-1,000
| -27% | -$90K | 0.01% | 231 |
|
|
2021
Q2 | $340K | Buy |
3,728
+777
| +26% | +$69.2K | 0.02% | 191 |
|
|
2021
Q1 | $252K | Sell |
2,951
-195
| -6% | -$17.5K | 0.02% | 217 |
|
|
2020
Q4 | $297K | Sell |
3,146
-250
| -7% | -$21.8K | 0.02% | 194 |
|
|
2020
Q3 | $295K | Sell |
3,396
-1,000
| -23% | -$86.6K | 0.02% | 184 |
|
|
2020
Q2 | $384K | Sell |
4,396
-276
| -6% | -$23.8K | 0.03% | 165 |
|
|
2020
Q1 | $385K | Buy |
4,672
+300
| +7% | +$26.8K | 0.04% | 152 |
|
|
2019
Q4 | $414K | Hold |
4,372
| – | – | 0.04% | 166 |
|
|
2019
Q3 | $380K | Hold |
4,372
| – | – | 0.03% | 168 |
|
|
2019
Q2 | $399K | Sell |
4,372
-644
| -13% | -$54.5K | 0.04% | 168 |
|
|
2019
Q1 | $432K | Buy |
5,016
+185
| +4% | +$14.9K | 0.04% | 160 |
|
|
2018
Q4 | $371K | Buy |
4,831
+889
| +23% | +$69.2K | 0.04% | 158 |
|
|
2018
Q3 | $304K | Buy |
3,942
+418
| +12% | +$30.9K | 0.03% | 181 |
|
|
2018
Q2 | $238K | Sell |
3,524
-45
| -1% | -$3.1K | 0.03% | 197 |
|
|
2018
Q1 | $259K | Buy |
3,569
+17
| +0.5% | +$1.29K | 0.03% | 195 |
|
|
2017
Q4 | $268K | Hold |
3,552
| – | – | 0.03% | 185 |
|
|
2017
Q3 | $273K | Hold |
3,552
| – | – | 0.03% | 177 |
|
|
2017
Q2 | $266K | Hold |
3,552
| – | – | 0.03% | 182 |
|
|
2017
Q1 | $236K | Buy |
3,552
+111
| +3% | +$7.4K | 0.03% | 183 |
|
|
2016
Q4 | $225K | Sell |
3,441
-1,060
| -24% | -$68.8K | 0.03% | 186 |
|
|
2016
Q3 | $318K | Sell |
4,501
-601
| -12% | -$43.8K | 0.04% | 167 |
|
|
2016
Q2 | $377K | Sell |
5,102
-101
| -2% | -$6.98K | 0.05% | 170 |
|
|
2016
Q1 | $337K | Buy |
5,203
+102
| +2% | +$6.94K | 0.05% | 163 |
|
|
2015
Q4 | $393K | Buy |
5,101
+108
| +2% | +$8.58K | 0.05% | 160 |
|
|
2015
Q3 | $411K | Buy |
4,993
+289
| +6% | +$25.7K | 0.06% | 148 |
|
|
2015
Q2 | $415K | Buy |
4,704
+417
| +10% | +$38.3K | 0.06% | 158 |
|
|
2015
Q1 | $379K | Buy |
4,287
+72
| +2% | +$6.39K | 0.05% | 162 |
|
|
2014
Q4 | $350K | Sell |
4,215
-746
| -15% | -$61.8K | 0.05% | 174 |
|
|
2014
Q3 | $418K | Sell |
4,961
-1,299
| -21% | -$105K | 0.06% | 152 |
|
|
2014
Q2 | $508K | Sell |
6,260
-1,060
| -14% | -$83.4K | 0.07% | 149 |
|
|
2014
Q1 | $557K | Buy |
7,320
+81
| +1% | +$5.9K | 0.08% | 139 |
|
|
2013
Q4 | $522K | Buy |
7,239
+29
| +0.4% | +$2.02K | 0.08% | 139 |
|
|
2013
Q3 | $496K | Buy |
7,210
+167
| +2% | +$11K | 0.08% | 134 |
|
|
2013
Q2 | $446K | Buy |
+7,043
| New | +$458K | 0.05% | 143 |
|
Other funds holding NVS
Stock Yards Bank & Trust's NVS Position: Q1 2026 in Review
Stock Yards Bank & Trust reduced its Novartis (NVS) stake by 11% in Q1 2026, selling an estimated $186K and leaving 10,027 shares worth $1.53M. The position accounts for 0.05% of the portfolio, ranked #179.
Stock Yards Bank & Trust first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.28M in Q2 2023. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Stock Yards Bank & Trust held 10,027 shares of Novartis worth $1.53M as of Q1 2026.
- Stock Yards Bank & Trust sold 1,216 Novartis shares in Q1 2026, an estimated $186K.
- Novartis made up 0.05% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #179 holding.
- Stock Yards Bank & Trust first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Stock Yards Bank & Trust's Novartis position peaked at $2.28M in Q2 2023.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.